Comparison of the clinical efficacy of paclitaxel + carboplatin and paclitaxel + cisplatin on tumor markers and WHOQOL-BREF score on cervical cancer patients.

MLA

Shanliang Hu, et al. “Comparison of the Clinical Efficacy of Paclitaxel + Carboplatin and Paclitaxel + Cisplatin on Tumor Markers and WHOQOL-BREF Score on Cervical Cancer Patients.” European Journal of Gynaecological Oncology, vol. 44, no. 6, Dec. 2023, pp. 142–49. EBSCOhost, https://doi.org/10.22514/ejgo.2023.109.

APA

Shanliang Hu, Chao Jiang, Weiwei Zhang, & Ping Fang. (2023). Comparison of the clinical efficacy of paclitaxel + carboplatin and paclitaxel + cisplatin on tumor markers and WHOQOL-BREF score on cervical cancer patients. European Journal of Gynaecological Oncology, 44(6), 142–149. https://doi.org/10.22514/ejgo.2023.109

Chicago

Shanliang Hu, Chao Jiang, Weiwei Zhang, and Ping Fang. 2023. “Comparison of the Clinical Efficacy of Paclitaxel + Carboplatin and Paclitaxel + Cisplatin on Tumor Markers and WHOQOL-BREF Score on Cervical Cancer Patients.” European Journal of Gynaecological Oncology 44 (6): 142–49. doi:10.22514/ejgo.2023.109.